T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$2.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 3 |
Broadcom
AVGO
|
+$1.61B |
| 4 |
Tesla
TSLA
|
+$1.59B |
| 5 |
Sempra
SRE
|
+$1.26B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.14B |
| 2 |
Amazon
AMZN
|
+$2.54B |
| 3 |
AET
Aetna Inc
AET
|
+$1.44B |
| 4 |
Biogen
BIIB
|
+$1.4B |
| 5 |
Netflix
NFLX
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 15.97% |
| 4 | Consumer Discretionary | 14.71% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
AbbVie
ABBV
$440B
| $574M | 0.09% |
6,064,246
-910,500
| -13% | -$100M |
|
227
United Airlines
UAL
$40.6B
| $569M | 0.09% |
8,183,842
-4,874,274
| -37% | -$337M |
|
228
RPM International
RPM
$14.7B
| $564M | 0.09% |
11,832,807
+7,291
| +0.1% | +$371K |
|
|
EVHC
229
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $564M | 0.09% |
14,665,461
-1,750,379
| -11% | -$65.4M |
|
230
Sherwin-Williams
SHW
$87.4B
| $562M | 0.09% |
4,300,383
-895,392
| -17% | -$122M |
|
231
Marathon Petroleum
MPC
$97.8B
| $557M | 0.09% |
7,615,295
-240,671
| -3% | -$16.6M |
|
232
AvalonBay Communities
AVB
$25.7B
| $551M | 0.09% |
3,351,200
+79,034
| +2% | +$13M |
|
233
McDonald's
MCD
$195B
| $549M | 0.09% |
3,509,960
-1,023,337
| -23% | -$168M |
|
234
Archer Daniels Midland
ADM
$38.4B
| $547M | 0.09% |
12,617,363
+308,554
| +3% | +$13M |
|
235
EQT Corp
EQT
$33.8B
| $533M | 0.08% |
20,626,696
+1,169,220
| +6% | +$33.6M |
|
236
Pediatrix Medical
MD
$2.15B
| $532M | 0.08% |
9,565,523
-342,166
| -3% | -$18.8M |
|
237
Valvoline
VVV
$4.25B
| $532M | 0.08% |
24,033,875
-1,646,140
| -6% | -$39.2M |
|
238
Northern Trust
NTRS
$35B
| $528M | 0.08% |
5,123,938
-630,410
| -11% | -$65.9M |
|
239
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.65B
| $527M | 0.08% |
408,509
+296,176
| +264% | +$380M |
|
240
AstraZeneca
AZN
$246B
| $527M | 0.08% |
7,528,104
+217,977
| +3% | +$15.1M |
|
241
Allegion
ALLE
$14.1B
| $525M | 0.08% |
6,159,558
-293,017
| -5% | -$24.6M |
|
|
CLGX
242
DELISTED
Corelogic, Inc.
CLGX
| $525M | 0.08% |
11,606,522
+188,615
| +2% | +$8.68M |
|
243
Webster Financial
WBS
$12.8B
| $524M | 0.08% |
9,460,504
+104,986
| +1% | +$5.93M |
|
|
GLIBA
244
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $524M | 0.08% |
+9,913,150
| New | +$520M |
|
|
ATHN
245
DELISTED
Athenahealth, Inc.
ATHN
| $524M | 0.08% |
3,660,581
+206,322
| +6% | +$28.2M |
|
246
Neurocrine Biosciences
NBIX
$15.9B
| $520M | 0.08% |
6,264,664
+33,634
| +0.5% | +$2.84M |
|
247
FirstEnergy
FE
$27.2B
| $511M | 0.08% |
15,038,776
+1,749,824
| +13% | +$56.2M |
|
248
Acadia Healthcare
ACHC
$2.95B
| $511M | 0.08% |
13,047,023
+2,083,336
| +19% | +$76.4M |
|
249
Procter & Gamble
PG
$335B
| $509M | 0.08% |
6,425,341
-641,866
| -9% | -$53.5M |
|
|
SGEN
250
DELISTED
Seagen Inc. Common Stock
SGEN
| $509M | 0.08% |
9,731,991
+1,933,345
| +25% | +$105M |
|
Similar funds
T. Rowe Price Associates's Q1 2018 Portfolio in Review
As of Q1 2018, T. Rowe Price Associates held 2,649 positions worth $629B, up 2.1% from $616B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q1 2018 filing shows 91 new, 1,526 increased, 842 reduced and 97 closed positions. Its largest new stake was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M. The largest sale was Apple, an estimated $6.14B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2018 buy was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M.
- T. Rowe Price Associates added most to Texas Instruments in Q1 2018, an estimated $2.29B increase.
- T. Rowe Price Associates's biggest Q1 2018 reduction was Apple, cutting an estimated $6.14B.
- T. Rowe Price Associates fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $395M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $629B portfolio in Q1 2018.
- T. Rowe Price Associates opened 91 new positions and closed 97 in Q1 2018.
- T. Rowe Price Associates's portfolio value rose 2.1% quarter-over-quarter to $629B.
Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.